Market Recap Check: Tempest Therapeutics Inc (TPST)’s Negative Finish at 0.80, Up/Down -4.15

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Tempest Therapeutics Inc (NASDAQ: TPST) closed at $0.80 in the last session, down -4.15% from day before closing price of $0.83. In other words, the price has decreased by -$4.15 from its previous closing price. On the day, 1.88 million shares were traded. TPST stock price reached its highest trading level at $0.844 during the session, while it also had its lowest trading level at $0.79.

Ratios:

We take a closer look at TPST’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 1.69. In the meantime, Its Debt-to-Equity ratio is 1.55 whereas as Long-Term Debt/Eq ratio is at 0.73.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 14, 2024, initiated with a Sector Outperform rating and assigned the stock a target price of $13.

On February 08, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 12 ’24 when Versant Venture Capital VI, L. bought 387,999 shares for $1.10 per share.

Versant Venture Capital VI, L. sold 400,000 shares of TPST for $540,040 on Aug 08 ’24. The 10% Owner now owns 597,940 shares after completing the transaction at $1.35 per share. On Aug 12 ’24, another insider, Versant Venture Capital VI, L., who serves as the 10% Owner of the company, sold 387,999 shares for $1.10 each. As a result, the insider received 426,993 and left with 209,941 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TPST now has a Market Capitalization of 34913680 and an Enterprise Value of 13496852.

Stock Price History:

Over the past 52 weeks, TPST has reached a high of $6.00, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is -21.09%, while the 200-Day Moving Average is calculated to be -63.34%.

Shares Statistics:

According to the various share statistics, TPST traded on average about 3.45M shares per day over the past 3-months and 1461820 shares per day over the past 10 days. A total of 43.64M shares are outstanding, with a floating share count of 39.62M. Insiders hold about 9.21% of the company’s shares, while institutions hold 5.50% stake in the company. Shares short for TPST as of 1730332800 were 2638101 with a Short Ratio of 0.72, compared to 1727654400 on 1861925. Therefore, it implies a Short% of Shares Outstanding of 2638101 and a Short% of Float of 12.620000000000001.

Most Popular